La Gamba Fabiola, Corrao Giovanni, Romio Silvana, Sturkenboom Miriam, Trifirò Gianluca, Schink Tania, de Ridder Maria
Janssen Pharmaceutica NV, Beerse, Belgium.
Center for Statistics, Interuniversity Institute for Biostatistics and Statistical Bioinformatics, Campus Diepenbeek, Diepenbeek, Belgium.
Pharmacoepidemiol Drug Saf. 2017 Oct;26(10):1213-1219. doi: 10.1002/pds.4280. Epub 2017 Aug 11.
Clustering of patients in databases is usually ignored in one-stage meta-analysis of multi-database studies using matched case-control data. The aim of this study was to compare bias and efficiency of such a one-stage meta-analysis with a two-stage meta-analysis.
First, we compared the approaches by generating matched case-control data under 5 simulated scenarios, built by varying: (1) the exposure-outcome association; (2) its variability among databases; (3) the confounding strength of one covariate on this association; (4) its variability; and (5) the (heterogeneous) confounding strength of two covariates. Second, we made the same comparison using empirical data from the ARITMO project, a multiple database study investigating the risk of ventricular arrhythmia following the use of medications with arrhythmogenic potential. In our study, we specifically investigated the effect of current use of promethazine.
Bias increased for one-stage meta-analysis with increasing (1) between-database variance of exposure effect and (2) heterogeneous confounding generated by two covariates. The efficiency of one-stage meta-analysis was slightly lower than that of two-stage meta-analysis for the majority of investigated scenarios. Based on ARITMO data, there were no evident differences between one-stage (OR = 1.50, CI = [1.08; 2.08]) and two-stage (OR = 1.55, CI = [1.12; 2.16]) approaches.
When the effect of interest is heterogeneous, a one-stage meta-analysis ignoring clustering gives biased estimates. Two-stage meta-analysis generates estimates at least as accurate and precise as one-stage meta-analysis. However, in a study using small databases and rare exposures and/or outcomes, a correct one-stage meta-analysis becomes essential.
在使用匹配病例对照数据的多数据库研究的单阶段荟萃分析中,数据库中患者的聚类情况通常被忽略。本研究的目的是比较这种单阶段荟萃分析与两阶段荟萃分析的偏倚和效率。
首先,我们通过在5种模拟场景下生成匹配病例对照数据来比较这两种方法,这些场景通过改变以下因素构建:(1)暴露-结局关联;(2)其在数据库之间的变异性;(3)一个协变量对该关联的混杂强度;(4)其变异性;以及(5)两个协变量的(异质性)混杂强度。其次,我们使用ARITMO项目的经验数据进行了相同的比较,ARITMO项目是一项多数据库研究,调查使用有致心律失常潜力的药物后发生室性心律失常的风险。在我们的研究中,我们特别研究了当前使用异丙嗪的影响。
对于单阶段荟萃分析,随着(1)暴露效应的数据库间方差增加以及(2)两个协变量产生的异质性混杂增加,偏倚也增加。在大多数研究场景中,单阶段荟萃分析的效率略低于两阶段荟萃分析。基于ARITMO数据,单阶段(OR = 1.50,CI = [1.08;2.08])和两阶段(OR = 1.55,CI = [1.12;2.16])方法之间没有明显差异。
当感兴趣的效应是异质性的时,忽略聚类的单阶段荟萃分析会给出有偏估计。两阶段荟萃分析产生的估计至少与单阶段荟萃分析一样准确和精确。然而,在使用小数据库以及罕见暴露和/或结局的研究中,正确的单阶段荟萃分析变得至关重要。